Free Newsletter
ALSO NOTED: States sued over prescription-tracking law; Watson challenges Warner Chilcott on birth control pill;
> Three health information companies are suing the states of Vermont and Maine to block laws that would prevent drug makers from tracking individual scrips written by individual doctors; the privacy laws are set to take effect January 1. Release
> Watson Pharmaceuticals has asked the FDA to approve its copycat of Femcon, a Warner Chilcott birth-control pill; Warner Chilcott, meanwhile, sued the generics maker to block the drug. Release
> Contract manufacturer SAFC says it's planning to add conjugation capabilities to its Missouri plant, aiming to target pharma clients developing novel anti-cancer drugs. Report
> The troubled PDL BioPharma has put out the 'for sale' sign in an attempt to find a buyer for the company as a whole or of its key assets. Report
> Perlegen Sciences and Roche's 454 Life Sciences have teamed up to conduct large scale genetic re-sequencing in DNA samples collected from people with specific responses to an undisclosed class of drug. Report
And Finally... Antibiotics might fight stroke, too: A small new study showed that minocycline administered within 24 hours of a stroke reduced brain damage and physical impairment. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: